Market revenue in 2020 | USD 1,490.2 million |
Market revenue in 2027 | USD 2,214.0 million |
Growth rate | 5.8% (CAGR from 2020 to 2027) |
Largest segment | Reagents & kits |
Fastest growing segment | Reagents & Kits |
Historical data covered | 2016 - 2019 |
Base year for estimation | 2020 |
Forecast period covered | 2021 - 2027 |
Quantitative units | Revenue in USD million |
Market segmentation | Reagents & Kits, Instruments |
Key market players worldwide | Grifols SA Ordinary Shares - Class A, Bio-Rad Laboratories Inc, Roche Holding AG ADR, Quotient Sciences, Abbott Laboratories, BioMerieux SA, Siemens Healthineers AG ADR, MedGenome, Beckman Coulter |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to blood transfusion diagnostics market will help companies and investors design strategic landscapes.
Reagents & kits was the largest segment with a revenue share of 65.29% in 2020. Horizon Databook has segmented the North America blood transfusion diagnostics market based on reagents & kits, instruments covering the revenue growth of each sub-segment from 2016 to 2027.
North America dominated the blood transfusion diagnostics market in 2020 and is expected to maintain its position during the forecast period. Increasing health awareness, high disposable income, favorable reimbursement policies, and well-established healthcare infrastructure are some of the key factors boosting the regional market.
The U.S. accounted for the leading share in North America. Key factors contributing to its dominance include local presence of major market players, easy availability of various assays for testing, and over 600 independent donation facilities. Independent blood centers collect over 60% of blood donations in the U.S. and are responsible for 25% of the Canadian blood collection supply.
However, shortfall in blood collection will result in pricing pressure on established market players, which can fluctuate current price level of the tests. This may restrain the regional market over the forecast period, as the spending capacity of end users has deteriorated with increasing inflation.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America blood transfusion diagnostics market, including forecasts for subscribers. This continent databook contains high-level insights into North America blood transfusion diagnostics market from 2016 to 2027, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account